These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 38279180)

  • 41. Sexual functioning, quality of life and pelvic pain 12 months after endometriosis surgery including vaginal resection.
    Setälä M; Härkki P; Matomäki J; Mäkinen J; Kössi J
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):692-8. PubMed ID: 22404128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre- and postsurgical medical therapy for endometriosis surgery.
    Chen I; Veth VB; Choudhry AJ; Murji A; Zakhari A; Black AY; Agarpao C; Maas JW
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003678. PubMed ID: 33206374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta-analysis.
    Yan H; Shi J; Li X; Dai Y; Wu Y; Zhang J; Gu Z; Zhang C; Leng J
    Fertil Steril; 2022 Dec; 118(6):1102-1116. PubMed ID: 36283862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pain Reduction With an Immersive Digital Therapeutic in Women Living With Endometriosis-Related Pelvic Pain: At-Home Self-Administered Randomized Controlled Trial.
    Merlot B; Elie V; Périgord A; Husson Z; Jubert A; Chanavaz-Lacheray I; Dennis T; Cotty-Eslous M; Roman H
    J Med Internet Res; 2023 Jun; 25():e47869. PubMed ID: 37260160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
    Yucel N; Baskent E; Karamustafaoglu Balci B; Goynumer G
    Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):560-563. PubMed ID: 29359457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigating the efficacy of transcranial direct current stimulation on chronic pain management in endometriosis patients: A randomized controlled trial protocol.
    Camila de Lima Alves da Silva T; da Silva Dantas H; Eduarda Macedo L; Duarte Martins T; Silva-Filho E; Pegado R; McLean L; Thereza Albuquerque Barbosa Cabral Micussi M
    PLoS One; 2024; 19(8):e0306405. PubMed ID: 39088433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between endometriosis and pelvic pain.
    Porpora MG; Koninckx PR; Piazze J; Natili M; Colagrande S; Cosmi EV
    J Am Assoc Gynecol Laparosc; 1999 Nov; 6(4):429-34. PubMed ID: 10548700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Guidelines for the management of painful endometriosis].
    Roman H; Puscasiu L
    Chirurgia (Bucur); 2008; 103(3):265-74. PubMed ID: 18717274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Japanese-style acupuncture for endometriosis-related pelvic pain in adolescents and young women: results of a randomized sham-controlled trial.
    Wayne PM; Kerr CE; Schnyer RN; Legedza AT; Savetsky-German J; Shields MH; Buring JE; Davis RB; Conboy LA; Highfield E; Parton B; Thomas P; Laufer MR
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):247-57. PubMed ID: 18794019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain.
    Blair HA
    Drugs; 2024 Apr; 84(4):449-457. PubMed ID: 38592603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protocol of randomized controlled trial of potentized estrogen in homeopathic treatment of chronic pelvic pain associated with endometriosis.
    Teixeira MZ; Podgaec S; Baracat EC
    Homeopathy; 2016 Aug; 105(3):240-249. PubMed ID: 27473545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice.
    Techatraisak K; Hestiantoro A; Ruey S; Banal-Silao MJ; Kim MR; Seong SJ; Thaufik S; Ahlers C; Shin SY; Lee BS
    BMC Womens Health; 2019 May; 19(1):68. PubMed ID: 31096979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of protocols for randomized sham-controlled trials of complex treatment interventions: Japanese acupuncture for endometriosis-related pelvic pain.
    Schnyer RN; Iuliano D; Kay J; Shields M; Wayne P
    J Altern Complement Med; 2008 Jun; 14(5):515-22. PubMed ID: 18537469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.
    Urits I; Adamian L; Miro P; Callan J; Patel PM; Patel M; Berger AA; Kassem H; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2020 Oct; 50(4 Suppl 1):197-215. PubMed ID: 33633426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgery vs. hormone-based treatment for pain control in deep infiltrating endometriosis: a retrospective cohort study.
    Rezende GP; Venturini MC; Kawagoe LN; Yela Gomes DA; Benetti-Pinto CL
    Curr Med Res Opin; 2022 Apr; 38(4):641-647. PubMed ID: 35060442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study.
    Harada T; Osuga Y; Suzuki Y; Fujisawa M; Fukui M; Kitawaki J
    Fertil Steril; 2022 Mar; 117(3):583-592. PubMed ID: 34895700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of moxibustion to treat primary dysmenorrhea at two interventional times: study protocol for a randomized controlled trial.
    Yang J; Yu S; Lao L; Yang M; Chen J; Luo X; Wang Y; Chen X; Li J; Zhu L; Zheng Q; Hu Y; Wu X; Liang F
    Trials; 2015 Jan; 16():35. PubMed ID: 25633584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.